NASDAQ Stock Exchange News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 900,
"returned": 10,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "a0a4e000-d8f4-4c2b-b5e3-6395ad8cc390",
"title": "Great Southern Bancorp Inc Reports Mixed Q1 Results, Earnings Per Share Above Estimates",
"description": "Earnings Per Share (EPS): Reported at $1.13, surpassing the estimated $1.04.Net Income: Achieved $13.4 million, slightly above the estimated $12.19 million.Rev",
"keywords": "GuruFocus, Article, News, GuruFocus Research, GSBC",
"snippet": "Great Southern Bancorp Inc (GSBC, Financial) released its 8-K filing on April 18, 2024, disclosing its financial results for the first quarter ended March 31, 2...",
"url": "https://www.gurufocus.com/news/2412476/great-southern-bancorp-inc-reports-mixed-q1-results-earnings-per-share-above-estimates",
"image_url": "https://static.gurufocus.com/logos/0C00000B4R.png?5",
"language": "en",
"published_at": "2024-04-18T11:33:36.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "GSBC",
"name": "Great Southern Bancorp, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 149.85027,
"sentiment_score": 0.364575,
"highlights": [
{
"highlight": "<em>Great</em> <em>Southern</em> <em>Bancorp</em> <em>Inc</em> (GSBC, Financial) released its 8-K filing on April 18, 2024, disclosing its financial results for the first quarter ended March 31, 2024. The company reported preliminary earnings of $1.13 per diluted common share, a decrease from $1.67 in the same period last year but an increase from $1.11 in the preceding quarter.",
"sentiment": 0.5499,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Great</em> <em>Southern</em> <em>Bancorp</em> <em>Inc</em>, a prominent bank holding company, is primarily engaged in originating various loans and offering a spectrum of banking services.",
"sentiment": 0.6124,
"highlighted_in": "main_text"
},
{
"highlight": "For more detailed financial analysis and future updates on <em>Great</em> <em>Southern</em> <em>Bancorp</em> <em>Inc</em>, stay tuned to GuruFocus.com.\n\nExplore the complete 8-K earnings release (here) from <em>Great</em> <em>Southern</em> <em>Bancorp</em> <em>Inc</em> for further details.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Great</em> <em>Southern</em> <em>Bancorp</em> <em>Inc</em> Reports Mixed Q1 Results, Earnings Per Share Above Estimates",
"sentiment": 0.296,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "7207d771-a774-49df-a6e3-be2fc8bc05ce",
"title": "Home Bancorp Inc (HBCP) Reports Q1 2024 Earnings: Surpasses Revenue Estimates, Declares Quarterly Dividend",
"description": "Net Income: Reported $9.2 million, surpassing the estimated $7.80 million.Earnings Per Share (EPS): Achieved $1.14, exceeding the estimated $0.97.Revenue: Post",
"keywords": "GuruFocus, Article, News, GuruFocus Research, HBCP",
"snippet": "On April 17, 2024, Home Bancorp Inc (HBCP, Financial) released its 8-K filing, announcing the financial results for the first quarter of 2024. The company repor...",
"url": "https://www.gurufocus.com/news/2412475/home-bancorp-inc-hbcp-reports-q1-2024-earnings-surpasses-revenue-estimates-declares-quarterly-dividend",
"image_url": "https://static.gurufocus.com/logos/0C000014JI.png?5",
"language": "en",
"published_at": "2024-04-18T11:33:14.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "HBCP",
"name": "Home Bancorp, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 94.46175,
"sentiment_score": 0.4178,
"highlights": [
{
"highlight": "On April 17, 2024, <em>Home</em> <em>Bancorp</em> <em>Inc</em> (HBCP, Financial) released its 8-K filing, announcing the financial results for the first quarter of 2024. The company reported a net income of $9.2 million, or $1.14 per diluted common share, marking a slight decrease from the previous quarter's $9.4 million, or $1.17 per diluted EPS.",
"sentiment": 0.296,
"highlighted_in": "main_text"
},
{
"highlight": "Company Overview\n\n<em>Home</em> <em>Bancorp</em> <em>Inc</em>, operating through its subsidiary Home Bank, N.A., focuses on attracting deposits and utilizing these funds across a diversified loan and investment portfolio. The primary sources of funds are customer deposits, loan and investment repayments, and borrowings from federal institutions.",
"sentiment": 0.4767,
"highlighted_in": "main_text"
},
{
"highlight": "Financial Performance and Strategic Growth\n\nThe first quarter of 2024 saw <em>Home</em> <em>Bancorp</em> achieving a solid loan growth rate of 6% on an annualized basis and an 8% growth in deposits. The net interest income totaled $28.9 million, slightly down by 1% from the previous quarter.",
"sentiment": 0.886,
"highlighted_in": "main_text"
},
{
"highlight": "With a cautious yet optimistic approach to expanding its loan and deposit portfolios, <em>Home</em> <em>Bancorp</em> is poised to maintain its trajectory of stable growth in the upcoming quarters.\n\nFor detailed financial figures and future projections, stakeholders and potential investors are encouraged to review the full 8-K filing.",
"sentiment": 0.8481,
"highlighted_in": "main_text"
},
{
"highlight": "Explore the complete 8-K earnings release (here) from <em>Home</em> <em>Bancorp</em> <em>Inc</em> for further details.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Home</em> <em>Bancorp</em> <em>Inc</em> (HBCP) Reports Q1 2024 Earnings: Surpasses Revenue Estimates, Declares Quarterly Dividend",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "0fc777b2-bd17-4186-a925-3ef118f6046f",
"title": "Texas Capital Bancshares Inc (TCBI) Q1 2024 Earnings: Misses Analyst EPS Projections Amidst Rising Costs",
"description": "Earnings Per Share (EPS): Reported at $0.46, falling short of the estimated $0.60.Net Income: Achieved $26.1 million, below the analyst forecast of $29.20 mill",
"keywords": "GuruFocus, Article, News, GuruFocus Research, TCBI",
"snippet": "Texas Capital Bancshares Inc (TCBI, Financial) released its 8-K filing on April 18, 2024, announcing its financial results for the first quarter of 2024. The co...",
"url": "https://www.gurufocus.com/news/2412472/texas-capital-bancshares-inc-tcbi-q1-2024-earnings-misses-analyst-eps-projections-amidst-rising-costs",
"image_url": "https://static.gurufocus.com/logos/0C00000CM6.png?5",
"language": "en",
"published_at": "2024-04-18T11:32:00.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "TCBI",
"name": "Texas Capital Bancshares, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 136.98547,
"sentiment_score": 0.2854,
"highlights": [
{
"highlight": "<em>Texas</em> <em>Capital</em> <em>Bancshares</em> <em>Inc</em> (TCBI, Financial) released its 8-K filing on April 18, 2024, announcing its financial results for the first quarter of 2024. The company, a prominent player in the banking sector, operates primarily in Texas' major metropolitan areas, offering a range of specialized lending products across the United States.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "Overall, while <em>Texas</em> <em>Capital</em> <em>Bancshares</em> faced some earnings pressure this quarter, its strategic initiatives and strong capital position may provide a foundation for future growth and stability. Investors and stakeholders will likely keep a close watch on how the bank manages its expense lines and credit quality in an evolving economic landscape.",
"sentiment": 0.743,
"highlighted_in": "main_text"
},
{
"highlight": "Explore the complete 8-K earnings release (here) from <em>Texas</em> <em>Capital</em> <em>Bancshares</em> <em>Inc</em> for further details.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Texas</em> <em>Capital</em> <em>Bancshares</em> <em>Inc</em> (TCBI) Q1 2024 Earnings: Misses Analyst EPS Projections Amidst Rising Costs",
"sentiment": -0.2263,
"highlighted_in": "title"
}
]
},
{
"symbol": "TCBIP",
"name": "Texas Capital Bancshares, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Financial Services",
"match_score": 136.98547,
"sentiment_score": 0.2854,
"highlights": [
{
"highlight": "<em>Texas</em> <em>Capital</em> <em>Bancshares</em> <em>Inc</em> (TCBI, Financial) released its 8-K filing on April 18, 2024, announcing its financial results for the first quarter of 2024. The company, a prominent player in the banking sector, operates primarily in Texas' major metropolitan areas, offering a range of specialized lending products across the United States.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "Overall, while <em>Texas</em> <em>Capital</em> <em>Bancshares</em> faced some earnings pressure this quarter, its strategic initiatives and strong capital position may provide a foundation for future growth and stability. Investors and stakeholders will likely keep a close watch on how the bank manages its expense lines and credit quality in an evolving economic landscape.",
"sentiment": 0.743,
"highlighted_in": "main_text"
},
{
"highlight": "Explore the complete 8-K earnings release (here) from <em>Texas</em> <em>Capital</em> <em>Bancshares</em> <em>Inc</em> for further details.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Texas</em> <em>Capital</em> <em>Bancshares</em> <em>Inc</em> (TCBI) Q1 2024 Earnings: Misses Analyst EPS Projections Amidst Rising Costs",
"sentiment": -0.2263,
"highlighted_in": "title"
}
]
},
{
"symbol": "TCBIL",
"name": "Texas Capital Bancshares, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "N/A",
"match_score": 136.98547,
"sentiment_score": 0.2854,
"highlights": [
{
"highlight": "<em>Texas</em> <em>Capital</em> <em>Bancshares</em> <em>Inc</em> (TCBI, Financial) released its 8-K filing on April 18, 2024, announcing its financial results for the first quarter of 2024. The company, a prominent player in the banking sector, operates primarily in Texas' major metropolitan areas, offering a range of specialized lending products across the United States.",
"sentiment": 0.6249,
"highlighted_in": "main_text"
},
{
"highlight": "Overall, while <em>Texas</em> <em>Capital</em> <em>Bancshares</em> faced some earnings pressure this quarter, its strategic initiatives and strong capital position may provide a foundation for future growth and stability. Investors and stakeholders will likely keep a close watch on how the bank manages its expense lines and credit quality in an evolving economic landscape.",
"sentiment": 0.743,
"highlighted_in": "main_text"
},
{
"highlight": "Explore the complete 8-K earnings release (here) from <em>Texas</em> <em>Capital</em> <em>Bancshares</em> <em>Inc</em> for further details.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Texas</em> <em>Capital</em> <em>Bancshares</em> <em>Inc</em> (TCBI) Q1 2024 Earnings: Misses Analyst EPS Projections Amidst Rising Costs",
"sentiment": -0.2263,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "be1a1ed1-6740-4598-bf65-c1c5815c97b6",
"title": "Ocular stock gains on trial win for diabetic retinopathy drug",
"description": "Ocular Therapeutix (OCUL stock gained on positive Phase 1 results for its retinal disease candidate Axpaxli in diabetic retinopathy. Read more here.",
"keywords": "",
"snippet": "Ocular Therapeutix (NASDAQ:OCUL) announced Thursday that its Phase 1 HELIOS study for retinal disease candidate Axpaxli generated positive results in patients w...",
"url": "https://seekingalpha.com/news/4090884-ocular-stock-gains-trial-win-diabetic-retinopathy-drug",
"image_url": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1402604571/image_1402604571.jpg?io=getty-c-w750",
"language": "en",
"published_at": "2024-04-18T11:30:02.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "OCUL",
"name": "Ocular Therapeutix, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 45.95398,
"sentiment_score": 0.5574,
"highlights": [
{
"highlight": "<em>Ocular</em> <em>Therapeutix</em> (<em>NASDAQ:OCUL</em>) announced Thursday that its Phase 1 HELIOS study for retinal disease candidate Axpaxli generated positive results in patients with diabetic retinopathy without diabetic macular edema (DME).",
"sentiment": 0.5574,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "c18db61f-3c73-4f05-aa07-f7415857c8bb",
"title": "Ocular Therapeutix™ Announces Positive Topline Phase 1 Data for AXPAXLI™ in Diabetic Retinopathy",
"description": "46.2% of patients demonstrated a 1- or 2-step improvement in the Diabetic Retinopathy Severity Scale (DRSS) at 40 weeks in the AXPAXLI arm, compared to 0%...",
"keywords": "Nasdaq:OCUL, Ocular Therapeutix, Inc.",
"snippet": "46.2% of patients demonstrated a 1- or 2-step improvement in the Diabetic Retinopathy Severity Scale (DRSS) at 40 weeks in the AXPAXLI arm, compared to 0% in th...",
"url": "https://www.globenewswire.com/news-release/2024/04/18/2865250/0/en/Ocular-Therapeutix-Announces-Positive-Topline-Phase-1-Data-for-AXPAXLI-in-Diabetic-Retinopathy.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/e2ff6070-e164-4804-b537-9e2f2e7a419c",
"language": "en",
"published_at": "2024-04-18T11:00:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "OCUL",
"name": "Ocular Therapeutix, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 102.363846,
"sentiment_score": 0.415714,
"highlights": [
{
"highlight": "., April 18, 2024 (GLOBE NEWSWIRE) -- <em>Ocular</em> <em>Therapeutix</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(<em>NASDAQ:OCUL</em>) (“Ocular”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization of innovative therapies for wet age-related macular degeneration (wet AMD), diabetic retinopathy (DR), and other diseases and conditions of the eye, today announced positive topline results from",
"sentiment": 0.8625,
"highlighted_in": "main_text"
},
{
"highlight": "Heier, Chief Scientific Officer (CSO) of <em>Ocular</em> <em>Therapeutix</em>.\n\n“It is promising that the efficacy signals seen to date in this Phase 1 study consistently favor AXPAXLI. These data demonstrated DRSS improvements and durability for up to 40 weeks,” said Dilsher Dhoot, MD.",
"sentiment": 0.7717,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>Ocular</em> <em>Therapeutix</em>, <em>Inc</em>.\n\n<em>Ocular</em> <em>Therapeutix</em>, <em>Inc</em>. is a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization of innovative therapies for wet age-related macular degeneration (wet AMD), diabetic retinopathy (DR), and other diseases and conditions of the eye.",
"sentiment": 0.7184,
"highlighted_in": "main_text"
},
{
"highlight": "DEXTENZA® is a registered trademark of <em>Ocular</em> <em>Therapeutix</em>, <em>Inc</em>. AXPAXLI™, PAXTRAVA™, and ELUTYX™ and <em>Ocular</em> <em>Therapeutix</em>™ are trademarks of <em>Ocular</em> <em>Therapeutix</em>, <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Investors\n\n<em>Ocular</em> <em>Therapeutix</em>\n\nDonald Notman\n\nChief Financial Officer\n\[email protected]\n\n\n\nJoyce Allaire\n\nLifeSci Advisors\n\[email protected]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Ocular</em> <em>Therapeutix</em>™ Announces Positive Topline Phase 1 Data for AXPAXLI™ in Diabetic Retinopathy",
"sentiment": 0.5574,
"highlighted_in": "title"
}
]
}
]
}
]
},
{
"uuid": "06cb7f99-149d-4fed-bdfd-01badbc85fed",
"title": "NeoGenomics announces senior leadership promotions (NASDAQ:NEO)",
"description": "NeoGenomics announces promotions within its senior leadership team.",
"keywords": "",
"snippet": "To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.\n\nIf you have an ad-blocker enabled you may be blocked from ...",
"url": "https://seekingalpha.com/news/4090872-neogenomics-announces-senior-leadership-promotions",
"image_url": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"language": "en",
"published_at": "2024-04-18T11:25:55.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "NEO",
"name": "NeoGenomics, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 95.15796,
"sentiment_score": 0,
"highlights": [
{
"highlight": "<em>NeoGenomics</em> announces senior leadership promotions (<em>NASDAQ:NEO</em>)",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "db2274d7-5f4d-4544-bedb-e520ee9be40c",
"title": "Stock Futures Rise as Semiconductor Shares Rebound; Fed's Interest Rate Decisions Awaited",
"description": "Thursday saw an uptick in S&P 500 and Nasdaq futures as semiconductor stocks began to recover from recent declines, while market participants looked forward to",
"keywords": "GuruFocus, Article, News, GuruFocus Research, AMD, NVDA, AMAT, MU, KEY, CMA, DHI",
"snippet": "Thursday saw an uptick in S&P 500 and Nasdaq futures as semiconductor stocks began to recover from recent declines, while market participants looked forward to ...",
"url": "https://www.gurufocus.com/news/2412469/stock-futures-rise-as-semiconductor-shares-rebound-feds-interest-rate-decisions-awaited",
"image_url": "https://static.gurufocus.com/logos/0C0000099E.png?20",
"language": "en",
"published_at": "2024-04-18T11:17:37.000000Z",
"source": "gurufocus.com",
"relevance_score": null,
"entities": [
{
"symbol": "AMD",
"name": "Advanced Micro Devices, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 23.449814,
"sentiment_score": 0.34,
"highlights": [
{
"highlight": "Premarket activity highlighted gains for semiconductor companies including <em>Advanced</em> <em>Micro</em> <em>Devices</em> (AMD, Financial), Nvidia (NVDA, Financial), and Applied Materials (AMAT, Financial), with increases ranging from 0.3% to 0.7%.",
"sentiment": 0.34,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "AMAT",
"name": "Applied Materials, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 18.63405,
"sentiment_score": 0.5267,
"highlights": [
{
"highlight": "Premarket activity highlighted gains for semiconductor companies including Advanced Micro Devices (AMD, Financial), Nvidia (NVDA, Financial), and <em>Applied</em> <em>Materials</em> (AMAT, Financial), with increases ranging from 0.3% to 0.7%.",
"sentiment": 0.5267,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "NVDA",
"name": "NVIDIA Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 13.804798,
"sentiment_score": 0.5267,
"highlights": [
{
"highlight": "Premarket activity highlighted gains for semiconductor companies including Advanced Micro Devices (AMD, Financial), <em>Nvidia</em> (NVDA, Financial), and Applied Materials (AMAT, Financial), with increases ranging from 0.3% to 0.7%.",
"sentiment": 0.5267,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MU",
"name": "Micron Technology, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 19.868124,
"sentiment_score": 0.7351,
"highlights": [
{
"highlight": "<em>Micron</em> <em>Technology</em> (MU, Financial) saw a notable rise of 1.7% following news reports of a substantial $6 billion grant from the U.S. Commerce Department, aimed at supporting the company's domestic chip manufacturing initiatives.",
"sentiment": 0.7351,
"highlighted_in": "main_text"
}
]
}
],
"similar": [
{
"uuid": "210d12f5-84e1-480e-a926-cb48b73eed8e",
"title": "Futures rise as chip stocks bounce back after sell-off By Reuters",
"description": "Futures rise as chip stocks bounce back after sell-off",
"keywords": "",
"snippet": "(Reuters) - Futures for the and the Nasdaq gained on Thursday as some chip stocks recouped losses after a sell-off, while investors awaited Federal Reserve poli...",
"url": "https://www.investing.com/news/economy/futures-rise-as-chip-stocks-bounce-back-after-selloff-3383978",
"image_url": "https://i-invdn-com.investing.com/news/SP500StandardandPoors500Index_800x533_L_1657544297.jpg",
"language": "en",
"published_at": "2024-04-18T10:07:48.000000Z",
"source": "investing.com",
"relevance_score": null,
"entities": [
{
"symbol": "AMD",
"name": "Advanced Micro Devices, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 24.445961,
"sentiment_score": 0.6705,
"highlights": [
{
"highlight": "Chipmakers such as <em>Advanced</em> <em>Micro</em> <em>Devices</em> (NASDAQ: ), Nvidia (NASDAQ: ) and Applied Materials (NASDAQ: ) gained between 0.3% and 0.7% in premarket trading.\n\nMicron Technology (NASDAQ: ) advanced 1.7% after a report that the memory-chip maker is set to get more than $6 billion in grants from the U.S.",
"sentiment": 0.6705,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "AMAT",
"name": "Applied Materials, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 19.630198,
"sentiment_score": 0.7579,
"highlights": [
{
"highlight": "Chipmakers such as Advanced Micro Devices (NASDAQ: ), Nvidia (NASDAQ: ) and <em>Applied</em> <em>Materials</em> (NASDAQ: ) gained between 0.3% and 0.7% in premarket trading.\n\nMicron Technology (NASDAQ: ) advanced 1.7% after a report that the memory-chip maker is set to get more than $6 billion in grants from the U.S.",
"sentiment": 0.7579,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "NVDA",
"name": "NVIDIA Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 14.800948,
"sentiment_score": 0.7579,
"highlights": [
{
"highlight": "Chipmakers such as Advanced Micro Devices (NASDAQ: ), <em>Nvidia</em> (NASDAQ: ) and Applied Materials (NASDAQ: ) gained between 0.3% and 0.7% in premarket trading.\n\nMicron Technology (NASDAQ: ) advanced 1.7% after a report that the memory-chip maker is set to get more than $6 billion in grants from the U.S.",
"sentiment": 0.7579,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MU",
"name": "Micron Technology, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 20.864258,
"sentiment_score": 0.6369,
"highlights": [
{
"highlight": "<em>Micron</em> <em>Technology</em> (NASDAQ: ) advanced 1.7% after a report that the memory-chip maker is set to get more than $6 billion in grants from the U.S. Commerce Department to help pay for domestic chip factory projects.",
"sentiment": 0.6369,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "DHI",
"name": "D.R. Horton, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 26.56401,
"sentiment_score": 0,
"highlights": [
{
"highlight": "With the first-quarter reporting season hitting its stride, investors will watch for earnings from lenders KeyCorp (NYSE: ), Comerica (NYSE: ) and homebuilder <em>D.R</em>. <em>Horton</em> before the opening bell.\n\nWeekly jobless claims and March existing home sales data due later in the day will also be on the radar in an otherwise light data calendar.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "LRN",
"name": "Stride, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Defensive",
"match_score": 15.791785,
"sentiment_score": 0,
"highlights": [
{
"highlight": "With the first-quarter reporting season hitting its <em>stride</em>, investors will watch for earnings from lenders KeyCorp (NYSE: ), Comerica (NYSE: ) and homebuilder D.R. Horton before the opening bell.\n\nWeekly jobless claims and March existing home sales data due later in the day will also be on the radar in an otherwise light data calendar.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "^GSPC",
"name": "S&P 500",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "index",
"industry": "N/A",
"match_score": 22.056803,
"sentiment_score": -0.4588,
"highlights": [
{
"highlight": "All three major indexes closed lower in the last session, with the <em>S</em>&<em>P</em> <em>500</em> and the Nasdaq logging their fourth straight day of losses as investors remained jittery about the Fed's interest-rate outlook.",
"sentiment": -0.4588,
"highlighted_in": "main_text"
}
]
}
]
},
{
"uuid": "b18b4155-70f6-437e-911e-2160307b796e",
"title": "Futures rise as chip stocks bounce back after sell-off",
"description": "Chipmakers such as Advanced Micro Devices, Nvidia and Applied Materials gained between 0.3% and 0.7% in premarket trading. Micron Technology advanced 1.7% after a report that the memory-chip maker is set to get more than $6 billion in grants from the U.S. Commerce Department to help pay for domestic chip factory projects.",
"keywords": "",
"snippet": "(Reuters) - Futures for the S&P 500 and the Nasdaq gained on Thursday as some chip stocks recouped losses after a sell-off, while investors awaited Federal Rese...",
"url": "https://finance.yahoo.com/news/futures-rise-chip-stocks-bounce-100115911.html",
"image_url": "https://media.zenfs.com/en/reuters-finance.com/e5adbac6f77023d098c23b36e4df7c4a",
"language": "en",
"published_at": "2024-04-18T10:01:15.000000Z",
"source": "finance.yahoo.com",
"relevance_score": null,
"entities": [
{
"symbol": "^GSPC",
"name": "S&P 500",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "index",
"industry": "N/A",
"match_score": 32.88616,
"sentiment_score": -0.266267,
"highlights": [
{
"highlight": "(Reuters) - Futures for the <em>S</em>&<em>P</em> <em>500</em> and the Nasdaq gained on Thursday as some chip stocks recouped losses after a sell-off, while investors awaited Federal Reserve policymakers' stance on interest-rate cuts in the face of resilient economic data.",
"sentiment": -0.34,
"highlighted_in": "main_text"
},
{
"highlight": "All three major indexes closed lower in the last session, with the <em>S</em>&<em>P</em> <em>500</em> and the Nasdaq logging their fourth straight day of losses as investors remained jittery about the Fed's interest-rate outlook.",
"sentiment": -0.4588,
"highlighted_in": "main_text"
},
{
"highlight": "ET, Dow e-minis were up 4 points, or 0.01%, <em>S</em>&<em>P</em> <em>500</em> e-minis were up 3.5 points, or 0.07%, and Nasdaq 100 e-minis were up 26.5 points, or 0.15%.\n\nWith the first-quarter reporting season hitting its stride, investors will watch for earnings from lenders KeyCorp, Comerica and homebuilder D.R. Horton before the opening bell.",
"sentiment": 0,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "AMD",
"name": "Advanced Micro Devices, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 23.449814,
"sentiment_score": 0.7783,
"highlights": [
{
"highlight": "Chipmakers such as <em>Advanced</em> <em>Micro</em> <em>Devices</em>, Nvidia and Applied Materials gained between 0.3% and 0.7% in premarket trading.\n\nMicron Technology advanced 1.7% after a report that the memory-chip maker is set to get more than $6 billion in grants from the U.S. Commerce Department to help pay for domestic chip factory projects.",
"sentiment": 0.7783,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "AMAT",
"name": "Applied Materials, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 18.63405,
"sentiment_score": 0.8316,
"highlights": [
{
"highlight": "Chipmakers such as Advanced Micro Devices, Nvidia and <em>Applied</em> <em>Materials</em> gained between 0.3% and 0.7% in premarket trading.\n\nMicron Technology advanced 1.7% after a report that the memory-chip maker is set to get more than $6 billion in grants from the U.S. Commerce Department to help pay for domestic chip factory projects.",
"sentiment": 0.8316,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "NVDA",
"name": "NVIDIA Corporation",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 13.804798,
"sentiment_score": 0.8316,
"highlights": [
{
"highlight": "Chipmakers such as Advanced Micro Devices, <em>Nvidia</em> and Applied Materials gained between 0.3% and 0.7% in premarket trading.\n\nMicron Technology advanced 1.7% after a report that the memory-chip maker is set to get more than $6 billion in grants from the U.S. Commerce Department to help pay for domestic chip factory projects.",
"sentiment": 0.8316,
"highlighted_in": "main_text"
}
]
},
{
"symbol": "MU",
"name": "Micron Technology, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Technology",
"match_score": 19.868124,
"sentiment_score": 0.6369,
"highlights": [
{
"highlight": "<em>Micron</em> <em>Technology</em> advanced 1.7% after a report that the memory-chip maker is set to get more than $6 billion in grants from the U.S. Commerce Department to help pay for domestic chip factory projects.\n\nThe Philadelphia Semiconductor Index, which dropped over 3% on Wednesday, was down nearly 13% from the record high levels seen last month.",
"sentiment": 0.6369,
"highlighted_in": "main_text"
}
]
}
]
}
]
},
{
"uuid": "f4cf0ea6-f31b-4ce1-843e-22ae152a9ff5",
"title": "Benitec Biopharma jumps 33% on $40M private financing (NASDAQ:BNTC)",
"description": "Benitec Biopharma's stock price surged 33% as the company announced a $40M private investment and pre-funded warrants, raising proceeds for clinical...",
"keywords": "",
"snippet": "To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.\n\nIf you have an ad-blocker enabled you may be blocked from ...",
"url": "https://seekingalpha.com/news/4090869-benitec-biopharma-jumps-33-on-40m-private-financing",
"image_url": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"language": "en",
"published_at": "2024-04-18T11:14:34.000000Z",
"source": "seekingalpha.com",
"relevance_score": null,
"entities": [
{
"symbol": "BNTC",
"name": "Benitec Biopharma Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 127.15827,
"sentiment_score": 0,
"highlights": [
{
"highlight": "<em>Benitec</em> <em>Biopharma</em> jumps 33% on $40M private financing (<em>NASDAQ:BNTC</em>)",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
},
{
"uuid": "81f024c1-50da-4fa7-8f2b-bad408e08c1e",
"title": "The Joint Corp. to Host Conference Call on Thursday, May",
"description": "SCOTTSDALE, Ariz., April 18, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The...",
"keywords": "Nasdaq:JYNT, The Joint Corp.",
"snippet": "SCOTTSDALE, Ariz., April 18, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiro...",
"url": "https://www.globenewswire.com/news-release/2024/04/18/2865266/32957/en/The-Joint-Corp-to-Host-Conference-Call-on-Thursday-May-2nd-to-Discuss-First-Quarter-2024-Results.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/13d47e5e-b299-479f-839e-c95ab47926eb",
"language": "en",
"published_at": "2024-04-18T11:05:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "JYNT",
"name": "The Joint Corp.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 91.68618,
"sentiment_score": 0.210167,
"highlights": [
{
"highlight": "., April 18, 2024 (GLOBE NEWSWIRE) -- <em>The</em> <em>Joint</em> <em>Corp</em>. (<em>NASDAQ</em>: <em>JYNT</em>), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced it will report its first quarter 2024 financial results on Thursday, May 2, 2024, after the market close. President and CEO Peter D.",
"sentiment": 0.4939,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>The</em> <em>Joint</em> <em>Corp</em>. (<em>NASDAQ</em>: <em>JYNT</em>)\n\n<em>The</em> <em>Joint</em> <em>Corp</em>. (<em>NASDAQ</em>: <em>JYNT</em>) revolutionized access to chiropractic care when it introduced its retail healthcare business model in 2010. Today, it is the nation's largest operator, manager and franchisor of chiropractic clinics through The Joint Chiropractic network.",
"sentiment": 0.4939,
"highlighted_in": "main_text"
},
{
"highlight": "Business Structure\n\n<em>The</em> <em>Joint</em> <em>Corp</em>. is a franchisor of clinics and an operator of clinics in certain states.",
"sentiment": 0.2732,
"highlighted_in": "main_text"
},
{
"highlight": "In Arkansas, California, Colorado, District of Columbia, Florida, Illinois, Kansas, Kentucky, Maryland, Michigan, Minnesota, New Jersey, New York, North Carolina, Oregon, Pennsylvania, Tennessee, Washington, and West Virginia, <em>The</em> <em>Joint</em> <em>Corp</em>. and its franchisees provide management services to affiliated professional chiropractic practices.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Contact Information\n\nMedia Contact: Margie Wojciechowski, <em>The</em> <em>Joint</em> <em>Corp</em>., [email protected]\n\nInvestor Contact: Kirsten Chapman, LHA Investor Relations, 415-433-3777, [email protected]",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "<em>The</em> <em>Joint</em> <em>Corp</em>. to Host Conference Call on Thursday, May",
"sentiment": 0,
"highlighted_in": "title"
}
]
},
{
"symbol": "FRGAP",
"name": "Franchise Group, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Cyclical",
"match_score": 17.590237,
"sentiment_score": 0.7526,
"highlights": [
{
"highlight": "Consistently named to <em>Franchise</em> Times \"Top 500+ Franchises\" and Entrepreneur's \"<em>Franchise</em> 500\" lists and recognized by FRANdata with the TopFUND award, as well as <em>Franchise</em> Business Review's \"Top <em>Franchise</em> for 2023,\" \"Most Profitable Franchises\" and \"Top Franchises for Veterans\" ranking, The Joint Chiropractic is an innovative force, where healthcare",
"sentiment": 0.9333,
"highlighted_in": "main_text"
},
{
"highlight": "To learn about <em>franchise</em> opportunities, visit www.thejointfranchise.com.\n\nBusiness Structure\n\nThe Joint Corp. is a franchisor of clinics and an operator of clinics in certain states.",
"sentiment": 0.5719,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "b112622d-4ce2-4d87-8cf4-00d7226d9d1a",
"title": "A category innovation: Pure Sunfarms introduces Hi-Def Pre-Rolls",
"description": "Leading LP Creates Game-Changing High THC Pre-Rolls",
"keywords": "",
"snippet": "This advertisement has not loaded yet, but your article continues below.\n\nA category innovation: Pure Sunfarms introduces Hi-Def Pre-Rolls\n\nArticle content Lead...",
"url": "https://financialpost.com/globe-newswire/a-category-innovation-pure-sunfarms-introduces-hi-def-pre-rolls",
"image_url": "https://dcs-static.gprod.postmedia.digital/15.9.0/websites/images/fp/favicon-fp.ico",
"language": "en",
"published_at": "2024-04-18T11:02:56.000000Z",
"source": "financialpost.com",
"relevance_score": null,
"entities": [
{
"symbol": "VFF",
"name": "Village Farms International, Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Consumer Defensive",
"match_score": 54.447342,
"sentiment_score": 0.267333,
"highlights": [
{
"highlight": "(“Pure Sunfarms”), a leading producer in the Canadian cannabis market and wholly owned subsidiary of <em>Village</em> <em>Farms</em> <em>International</em>, <em>Inc</em>. (<em>Nasdaq</em>: <em>VFF</em>), introduces the next product in the evolution of cannabis, Hi-Def Pre-Rolls.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Pure Sunfarms is a wholly owned subsidiary of <em>Village</em> <em>Farms</em> <em>International</em>, <em>Inc</em>. (<em>Nasdaq</em>: <em>VFF</em>).\n\nAdvertisement 4 Story continues below This advertisement has not loaded yet, but your article continues below.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "Article content www.puresunfarms.com About <em>Village</em> <em>Farms</em> <em>International</em> Village Farms leverages decades of experience as a large-scale, Controlled Environment Agriculture-based, vertically integrated supplier for high-value, high-growth plant-based Consumer Packaged Goods opportunities, with a strong foundation as a leading fresh produce supplier to",
"sentiment": 0.802,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
},
{
"uuid": "4ad3f7e0-c690-47aa-bab9-d3488e1170b2",
"title": "Chemomab Reports New Peer-Reviewed Publication Reinforcing the Clinical Association of Its CCL24 Target with Disease Severity and Mortality in Patients with Systemic Sclerosis",
"description": "Peer-reviewed patient study validates Chemomab's CCL24 as a novel target linked to greater disease severity and higher mortality in systemic sclerosis...",
"keywords": "Nasdaq:CMMB, Chemomab Therapeutics, Chemomab, CM-101, systemic sclerosis",
"snippet": "—Longitudinal Study of a 200+ Real-World Patient Cohort Further Validates CCL24 as a Novel Target for Systemic Sclerosis (SSc), Showing that It is Associated ...",
"url": "https://www.globenewswire.com/news-release/2024/04/18/2865252/0/en/Chemomab-Reports-New-Peer-Reviewed-Publication-Reinforcing-the-Clinical-Association-of-Its-CCL24-Target-with-Disease-Severity-and-Mortality-in-Patients-with-Systemic-Sclerosis.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/07e28ce3-bf66-48fd-a935-293d63b15b7e",
"language": "en",
"published_at": "2024-04-18T11:00:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "CMMB",
"name": "Chemomab Therapeutics Ltd.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 73.094376,
"sentiment_score": 0.672033,
"highlights": [
{
"highlight": "—Longitudinal Study of a 200+ Real-World Patient Cohort Further Validates CCL24 as a Novel Target for Systemic Sclerosis (SSc), Showing that It is Associated with Disease Severity Across the Fibrotic and Vascular Manifestations of SSc—\n\n\n\nTEL AVIV, Israel, April 18, 2024 (GLOBE NEWSWIRE) -- <em>Chemomab</em> <em>Therapeutics</em> <em>Ltd</em>.",
"sentiment": 0.5719,
"highlighted_in": "main_text"
},
{
"highlight": "(<em>Nasdaq</em>: <em>CMMB</em>), (Chemomab), a clinical stage biotechnology company developing innovative therapeutics to treat rare fibro-inflammatory diseases with high unmet need, today announced the publication of a new study that further confirms the key role of its novel soluble protein target CCL24 in systemic sclerosis (SSc).",
"sentiment": 0.7845,
"highlighted_in": "main_text"
},
{
"highlight": "About <em>Chemomab</em> <em>Therapeutics</em> <em>Ltd</em>.\n\nChemomab is a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need. Based on the unique and pivotal role of CCL24 in promoting fibrosis and inflammation, Chemomab developed CM-101, a monoclonal antibody that neutralizes CCL24 activity.",
"sentiment": 0.6597,
"highlighted_in": "main_text"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "NASDAQ",
"total_documents": 1386,
"sentiment_avg": 0.22741225941720228
}
]
}
Other details
Country
- us
- 5,275